The Binding Site

The Binding Site — FDA 510(k) Submissions

The Binding Site has submitted 10 FDA 510(k) premarket notifications since 2004, of which 10 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Method, Nephelometric, Immunoglobulins (g, A, M), Immunoglobulin G Kappa Heavy And Light Chain Combined, Immunoglobulin A Kappa Heavy & Light Chain Combined, Autoantibodies, Endomysial(tissue Transglutaminase), System, Test, Rheumatoid Factor . Use the specialty filter in the sidebar to narrow results.